Extracorporeal Membrane Oxygenation Cannula Market By Cannula Type (Venous Cannula, Arterial Cannula, Veno-Arterial (VA) Cannula, Veno-Venous (VV) Cannula), By Design (Single-Stage Cannula, Multi-Stage Cannula, Femoral Cannula, Jugular Cannula, Avalon Cannula), By Material (Polyurethane, Silicone, Polyvinyl Chloride, Others), By Application (Cardiac Applications {Cardiogenic Shock, Cardiac Arrest, Post-Cardiotomy Support}, Respiratory Applications {Acute Respiratory Distress Syndrome, Pulmonary Embolism, Pneumonia}, Extracorporeal Cardiopulmonary Resuscitation), By Distribution Channel (Direct Sales, Distributor, Online Channels), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Cardiac & Respiratory Care Centers, Academic & Research Institutes), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles and Market Forecast, 2025 – 2035

---

Industry Outlook

The Extracorporeal Membrane Oxygenation Cannula Market accounted for USD 33.49 Million in 2024 and USD 35.10 Million in 2025 is expected to reach USD 56.15 Million by 2035, growing at a CAGR of around 4.81% between 2025 and 2035. Extracorporeal Membrane Oxygenation cannula is a life-saving medical device used in the extracorporeal membrane oxygenation process, in which it helps to draw blood from and return oxygenated blood to the patient’s body when there is severe heart or lung failure. These cannulas are placed either in big veins or arteries, and they provide the Extracorporeal Membrane Oxygenation machine with the necessary entry points for it to fulfil its life-saving roles. Increased awareness, increased intensive care capacity, and technological innovations in cannula designs are sparking the uptake of Extracorporeal Membrane Oxygenation cannulas in hospitals across the world, which have made them important elements in emergency and specialized healthcare.

Industry Experts Opinion

"Teaching the techniques for cannulating and exchanging the cannula for extracorporeal circulation support is indispensable in cardiac surgical training.’’

• Dr. Chih-Hsien Wang and Dr. Shu-Chien Huang, in their commentary on JTCVS Techniques

Report Scope:

Market Dynamics

The rising incidence of cardiac and respiratory failure is driving demand for Extracorporeal Membrane Oxygenation procedures.

Increasing cardiac and respiratory failure is one of the key drivers of the increasing demand in the Extracorporeal Membrane Oxygenation Cannula Market. The current lifestyles, growing populations that are ageing, and the proliferation of chronic ailments such as heart disease, sepsis, and severe pneumonia have led to a dramatic increase in the incidence of acute cardiac and pulmonary failure. When in such critical situations, Extracorporeal Membrane Oxygenation becomes a life-saving technology by performing the heart and lung functions as an artificial provision to buy time for recovery or transfers to subsequent treatments such as transplants. This has resulted in an increasing use of Extracorporeal Membrane Oxygenation systems in intensive care units (ICUs), and with it comes the necessity to use high-performance cannulas that guarantee blood flow is carried out safely and effectively.

Extracorporeal Membrane Oxygenation cannulas are very important in ensuring that the Extracorporeal Membrane Oxygenation procedure is undertaken efficiently because they facilitate easy drainage and reinfusion, a factor that is important in venovenous and veno-arterial support. As other hospitals and healthcare providers strive to increase the survival rates among organ failure patients, the implementation of Extracorporeal Membrane Oxygenation is spreading to both developed and developing regions. Extracorporeal Membrane Oxygenation was also seen to be valuable during the COVID-19 pandemic, increasing awareness and acceptability of the technology. With an ever-increasing number of cases requiring advanced life support that can only be offered by Extracorporeal Membrane Oxygenation setups and consumables, such as cannulas, hospitals are investing more in Extracorporeal Membrane Oxygenation setups and consumables, hence directly boosting the growth of the market.

The growing use of Extracorporeal Membrane Oxygenation support in critical care and emergency settings boosts the need for cannulas.

The escalating consumption of Extracorporeal Membrane Oxygenation support in critical care and emergency scenarios is the most important driver. Extracorporeal Membrane Oxygenation is gaining attention and is a growing trend in intensive care units (ICUs), emergency departments, and trauma centers to assist patients who are experiencing life-threatening cardiac or respiratory failure. As there have been enhancements in technological advancements of Extracorporeal Membrane Oxygenation, together with improved education of healthcare professionals, the use of Extracorporeal Membrane Oxygenation has been widely extended from postoperative support to emergency rescue. In such cases, the Extracorporeal Membrane Oxygenation Cannulas are vital for the rapid establishment of extracorporeal circulation; hence, they are crucial equipment in the emergency response procedures for patients in grave condition.

In emergency cases, time-conscious and hard situations require readily inserted cannulas capable of providing immediate blood access without complications. The flexibility and effectiveness of Extracorporeal Membrane Oxygenation Cannulas are the reason why it is indispensable in caring for patients suffering from sudden cardiac arrest and trauma, or serious infections such as sepsis. This trend is further embraced by the increased number of trained Extracorporeal Membrane Oxygenation specialists and the incorporation of Extracorporeal Membrane Oxygenation in the resuscitation guidelines in several hospitals. The demand for performing Extracorporeal Membrane Oxygenation procedures is increasing in such urgent care settings, and the concomitant increase in demand for high-end cannulas is intensifying the market remarkably.

The high cost of Extracorporeal Membrane Oxygenation procedures and equipment limits accessibility in low-resource settings.

Some of the key inhibitors that would impede the growth of the Extracorporeal Membrane Oxygenation Cannula Market are the high cost concerning procedures and equipment. The establishment of an Extracorporeal Membrane Oxygenation system means that a lot of money is involved, from the machine as well as special cannulas, tubings, monitors, and highly trained medical staff. The total treatment cost, which involves ICU lengths of stay and post-extracorporeal Membrane Oxygenation care, may be quite high. This makes it less available, particularly in low-resource or rural healthcare where the budget is low and equipment or advanced technologies are not always available.

With these high costs, many hospitals in developing countries or under-funded locations cannot afford it, even though they have severely ill patients to whom it could help. Despite the advanced countries, high operational costs do not allow the use of Extracorporeal Membrane Oxygenation machines in the majority of secondary care hospitals or tertiary care hospitals. This fiscal obstacle frustrates the general market expansion due to the delayed adoption of Extracorporeal Membrane Oxygenation cannulas and devices. Absent broader financial support, subsidies, or relatively cheap technological innovations, the availability and use of Extracorporeal Membrane Oxygenation cannulas in such settings are still an issue.

Increasing healthcare investment in developing countries creates new market avenues.

Expansion in investment in healthcare facilities in developing countries is creating immense opportunities for the growth of the Extracorporeal Membrane Oxygenation Cannula Market. Governments all around Asia, Africa, and Latin America are enlarging hospital infrastructure, ICU capacity, and access to advanced medical technologies through an increased healthcare budget. This growth includes the increasing installation of life-saving technologies such as Extracorporeal Membrane Oxygenation systems that in the past were only reserved for high-end facilities. This trend is opening new doors for the demand and supply of Extracorporeal Membrane Oxygenation cannulas, particularly as these regions focus on modernizing their critical care services.

Besides public money, private hospitals and international initiatives also play a vital role in improving healthcare delivery in emerging economies. Higher training of medical personnel, familiarization with state-of-the-art treatments, and the increasing number of specialised cardiac and respiratory centres also contribute to the implementation of Extracorporeal Membrane Oxygenation procedures. With the increasing demand for Extracorporeal Membrane Oxygenation therapy in these regions, there arises the need for reliable and more cost-effective cannulas. Easy to install, easy to operate, and cheap Extracorporeal Membrane Oxygenation cannulas will create an excellent opportunity for manufacturers to penetrate untapped markets. These are ideal for meeting the increasing need for healthcare in developing areas.

Expanding the use of Extracorporeal Membrane Oxygenation in pediatric and neonatal care presents growth potential.

With the rapidly increasing applications for Extracorporeal Membrane Oxygenation in pediatric and neonatal care, the Extracorporeal Membrane Oxygenation Cannula Market has gained a massive growth opportunity. Nowadays, it is more commonly used for treating critical newborns and children with critically low respiratory and cardiac conditions, such as congenital heart defects, pulmonary hypertension, and respiratory distress syndrome. The pediatric and neonatal patients, because of their smaller sizes and special physiological needs, will require specially developed cannulas, which are delicate but effective. As more healthcare providers implement Extracorporeal Membrane Oxygenation as a life-saving procedure for younger patients, the need for pediatric-oriented cannula designs is likely to increase gradually.

Pediatric hospitals and neonatal intensive care units (NICUs) are making investments in high-end Extracorporeal Membrane Oxygenation equipment to increase the rate of survival in high-risk neonates and kids. With increasing awareness, improved medical education, and technological advances that can be custom-made for use by the young, the prospects for market growth in this segment are massive. There is a prospect for manufacturers interested in tailoring small-sized, safe, and non-invasive cannulas for a young patient population. The diversification of offerings not only takes place in this segment but also accommodates the changing aspects of Extracorporeal Membrane Oxygenation usage with age groups, which can prove to be growth drivers for the Extracorporeal Membrane Oxygenation Cannula Market in the long run.

Segment Analysis

Based on Cannula Type, the Extracorporeal Membrane Oxygenation Cannula Market is segmented into Venous Cannula, Arterial Cannula, Veno-Arterial (VA) Cannula, and Veno-Venous (VV) Cannula. The Veno-Arterial (VA) Cannula is dominating the market because it is essential for both the heart and the lungs in Extracorporeal Membrane Oxygenation procedures. It is heavily utilized among patients with critical cardiac and respiratory failure because it provides full cardiopulmonary support. Increased cases of cardiovascular diseases and an increase in emergency surgeries are also fuelling the demand for VA cannulas in hospitals and intensive care units. Its capacity to handle critical life-threatening conditions makes it the preferred choice, especially in high-risk situations.

Based on Design, the Extracorporeal Membrane Oxygenation Cannula Market is segmented into Single-Stage Cannula, Multi-Stage Cannula, Femoral Cannula, Jugular Cannula, and Avalon Cannula. The Avalon Cannula segment has a considerable share of the market due to its dual-lumen properties that enable both the venous drain as well as reinfusion via a single inlet. This distinctive property makes setting up the Extracorporeal Membrane Oxygenation easier, makes fewer cannulas necessary, and limits the complications for the patients. It is especially frequent during venovenous Extracorporeal Membrane Oxygenation when we are referring to severe respiratory failure. Increased interest in minimally invasive procedures and better comfort of the patient is driving the incorporation of Avalon cannulas in sophisticated healthcare environments.

Regional Analysis

The North American Extracorporeal Membrane Oxygenation Cannula market is experiencing steady growth, fueled by the region's sophisticated healthcare infrastructure, high awareness of critical care technologies, and growing adoption of extracorporeal membrane oxygenation procedures in adult as well as pediatric care. Top players in the region emphasize continuous innovation in cannula design, focusing on less invasiveness, enhanced biocompatibility, and optimized flow dynamics. The accessibility of prominent medical device companies and solid clinical research efforts ensures continued growth and acceptance of such systems. The increasing incidence of cardiopulmonary disease and increasing requirement for life-support therapy during severe illness also fuel market interest. The region is also facilitated by a supportive regulatory framework and comprehensive training efforts, ensuring the correct use and integration of extracorporeal membrane oxygenation technologies within intensive care units.

The Asia-Pacific Extracorporeal Membrane Oxygenation Cannula Market is witnessing the fastest growth, owing to the growth in healthcare infrastructure, rising prevalence of cardiovascular diseases, and enhanced awareness of advanced medical treatments. China, India, and Japan are leading the world in this growth. For instance, China has a heavy burden of cardiovascular diseases, contributing to about 47% and 44% of mortality rates in rural and urban areas, respectively, by 2019. The growing number of patients who are receiving Extracorporeal Membrane Oxygenation therapy under government support and the recent entry of international market players are expected to fuel dramatic growth of the market in the forthcoming years.

Competitive Landscape

The competitive landscape of the Extracorporeal Membrane Oxygenation Cannula Market is characterized by the presence of established medical device players who concentrate on product innovation, global expansion and strategic alliance. Some of the major players in this market include Medtronic; Getinge AB; LivaNova PLC; Terumo Corporation; and Nipro Medical Corporation. These companies are constantly spending on research and development to increase cannula design for improved efficiency, patient safety, and easy insertion.

Other than global titans, emerging players and regional manufacturers are penetrating the market with affordable and technologically advanced solutions, particularly in developing countries. Associations with hospitals and emphasis on training programs for the clinicians as well as regulatory approvals are other important strategies that have been taken by these players to improve their market share.

Extracorporeal Membrane Oxygenation Cannula Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In January of 2024, LivaNova PLC said it would be winding down its Advanced Circulatory Support (ACS) business as a way of enhancing its strategic focus on its Neuromodulation and Cardiopulmonary (CP) business. Livanova will keep all ACS cannulae products via the CP business unit product catalog

Report Coverage:

By Cannula Type

• Venous Cannula
• Arterial Cannula
• Veno-Arterial (VA) Cannula
• Veno-Venous (VV) Cannula

By Design

• Single-Stage Cannula
• Multi-Stage Cannula
• Femoral Cannula
• Jugular Cannula
• Avalon Cannula

By Material

• Polyurethane
• Silicone
• Polyvinyl Chloride
• Others

By Application

• Cardiac Applications

• Cardiogenic Shock
• Cardiac Arrest
• Post-Cardiotomy Support

• Respiratory Applications

• Acute Respiratory Distress Syndrome
• Pulmonary Embolism
• Pneumonia

• Extracorporeal Cardiopulmonary Resuscitation

By Distribution Channel

• Direct Sales
• Distributor
• Online Channels

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cardiac & Respiratory Care Centers
• Academic & Research Institutes

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Medtronic
• Getinge AB
• LivaNova PLC
• Terumo Corporation
• Fresenius Medical Care
• Abbott Laboratories
• Nipro Corporation
• Edwards Lifesciences
• OriGen Biomedical
• MC3 Cardiopulmonary
• Euro sets
• Maquet
• Spectrum Medical
• Xenios AG
• Baxter International Inc.

Frequently Asked Questions (FAQs)